![]() |
|
|
Vol. 293, Issue 1, 67-74, April 2000
4 and
6 Nicotinic Receptor Subunits
in Regulating Nicotine-Induced Seizures1
Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado
| |
Abstract |
|---|
|
|
|---|
Several studies have shown that genetic factors influence sensitivity
to nicotine-induced seizures in the mouse. We used recombinant inbred
(RI) strains derived from the Long-Sleep (LS) and Short-Sleep (SS)
mouse lines to assess the possibility that polymorphisms associated
with one or more of the nicotinic receptors cosegregate with
differential sensitivity to nicotine-induced seizures. Restriction fragment length polymorphisms (RFLPs) associated with the
2,
3,
4,
5, and
6 nicotinic receptors were identified in the LS and
SS mouse lines, but the RI strains were polymorphic for only the
4
and
6 RFLPs. The RI strains were tested for sensitivity to
nicotine-induced seizures. Strain and gender effects on seizure sensitivity were obtained as assessed by ED50 values and
latency to seizure. Those RI strains with the LS-like
4 RFLP were,
on average, more sensitive to nicotine-induced seizures than were those
RI strains with SS-like
4 RFLP. The
6 nicotine receptor may also
play a role in modulating nicotine-induced seizures, but this effect is
markedly influenced by gender. Females of the RI strains with the
LS-like
6 RFLP were more sensitive to nicotine than were females of
the strains with the SS-like
6 RFLP. Similar trends were seen in the
males, but these trends were not significant. Thus, these strain
differences may be due to polymorphisms associated with both the
4
and
6 nicotinic receptors, but gender also plays an important role
in regulating sensitivity to nicotine-induced seizure.
| |
Introduction |
|---|
|
|
|---|
A
very high percentage (80-90%) of alcoholics smoke, whereas 25 to 30%
of all adult Americans are smokers (Batel et al., 1995
). Unfortunately, very few studies have attempted to provide an
explanation for this often-made observation. One possibility relates to
the finding that both alcoholism and tobacco (nicotine) abuse appear to
be regulated, in part, by genetic factors (see Heath and Madden, 1995
,
for a recent review), and recent reports suggest that one or more of
the genes that influence alcohol use also influence tobacco use (Madden
et al., 1995
, 1997
). Thus, it may be that the co-use and abuse of
alcohol and nicotine has a genetic basis.
Sensitivity to one or more of the behavioral effects of alcohol may be
an important genetically determined factor that influences the
development of alcoholism (Moss et al., 1989
; Schuckit and Smith,
1996
). Apparently, individuals who are less sensitive to the
intoxicating effects of alcohol are more likely than alcohol-sensitive individuals to become alcoholics by their early 30s. Similarly, several
studies have suggested that sensitivity to the behavioral and
physiological actions of nicotine influences whether experimentation with tobacco progresses to tobacco abuse (reviewed in Pomerleau, 1995
).
These results suggest that identifying the factors that influence
sensitivity to alcohol and nicotine may help identify the genes that
regulate addiction to alcohol and tobacco.
A series of studies carried out in our laboratory have attempted to
determine, using rodent (mouse and rat) models, whether common genes
regulate sensitivity to alcohol and nicotine. Most of these studies
assessed the sensitivity to nicotine of two mouse lines that were
selectively bred for differential sensitivity to the depressant effects
of alcohol (de Fiebre et al., 1987
, de Fiebre and Collins, 1992
). These
two mouse lines, designated Long-Sleep (LS) and Short-Sleep (SS), were
selectively bred for differences in duration of ethanol-induced loss of
the righting response or sleep-time (McClearn and Kakihana, 1973
).
Outbreeding was maintained as the LS and SS mice were being selectively
bred. One outcome of this procedure is that the ethanol-sensitive LS mice should differ from the ethanol-resistant SS mice at the genes that
affect the duration of ethanol-induced sleep time. Thus, asking whether
the LS and SS mice also differ in sensitivity to nicotine addressed the
question of whether one or more of the genes that influence sensitivity
to the anesthetic effects of alcohol also influence sensitivity to nicotine.
The LS mice are slightly more sensitive than the SS mice to several
behavioral and physiological effects produced by nicotine injection (de
Fiebre et al., 1987
; de Fiebre and Collins, 1992
). This difference in
sensitivity is not likely due to differences in nicotine metabolism
because no overall differences in nicotine metabolism were found
between the LS and SS mice (de Fiebre et al., 1987
). Consequently, it
may be that the differential sensitivity of the LS and SS mice is due
to differences in neuronal sensitivity to nicotine. However, modest
gender differences in nicotine disposition were found in both the LS
and SS mice, which may explain why females of both lines are more
sensitive to nicotine than are the males (de Fiebre et al., 1987
).
It is well established that the actions of nicotine are initiated by
binding to nicotinic cholinergic receptors. Nicotinic receptors are
found at the skeletal neuromuscular junction, in autonomic ganglia, and
in the brain and spinal cord. Ten genes have been cloned and sequenced
that encode for neuronal nicotinic receptors (reviewed in Lindstrom,
1997
). In situ hybridization studies indicate that some of the subunits
are likely to be expressed in only a few brain regions (e.g.,
2,
5,
6,
3, and
4), whereas others are found throughout the
brain (
4,
7, and
2).
In the results reported here, the LS and SS mice were screened for
polymorphisms in all of the nicotinic receptor subunit genes, except
9 and
3, using the restriction fragment length polymorphism
(RFLP) approach. Polymorphisms were found in several of the genes. The
potential role of these polymorphisms in regulating sensitivity to the
seizure-inducing effects of nicotine was evaluated by comparing the
segregation pattern of the RFLP with sensitivity to nicotine-induced
seizures using the recombinant inbred (RI) strains that were derived
from the LS and SS mice (De Fries et al., 1989
).
| |
Materials and Methods |
|---|
|
|
|---|
Animals. LS and SS mice and the 26 surviving RI strains derived from them were maintained at the specific pathogen-free mouse colony at the Institute for Behavioral Genetics. The RI strains were derived by crossing the LS and SS mice to yield the F1 generation of animals, which were then crossed to yield the F2 generation. Forty sibling pairs from the F2 population were chosen at random to serve as the progenitors for the RI strains. Only 26 of the strains were available at the time this project was started. Mice were maintained on a 12-h light/dark cycle (lights on between 7:00 AM and 7:00 PM) and had free access to food (Teklad 22/5 rodent diet; Harlan, Madison, WI) and water.
Behavioral Testing. For seizure testing, the RI animals were injected i.p. with nicotine. Nicotine (base) was dissolved in isotonic saline. Concentrations were adjusted so that each dose was injected in a volume of 0.01 ml/g. Each animal was tested only once. The nicotine doses used ranged from 1.5 to 6.5 mg/kg and varied depending on the RI strain. After injection, animals were placed in a clear Plexiglas box and observed for clonic-tonic seizures over a period of 5 min. When clonic-tonic seizures were observed, the time postinjection required to evoke the initial convulsion (latency) was recorded. Animals that did not seize were assigned a latency score of 300 s. All animals were tested between 60 and 90 days of age, and approximately equal numbers of each gender were tested.
DNA Isolation.
Spleens were quick-frozen in isopentane kept
at
70°C and subsequently crushed into a fine powder with a mortar
and pestle. The crushed spleens were placed into 3 ml of a solution
containing 20 mM Tris, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5% SDS, and
10 mg/ml proteinase K and incubated for 3 to 5 h at 56°C. After
incubation, the samples were sequentially extracted with equal volumes
of phenol, phenol/chloroform/isoamyl alcohol (25:24:1), and
chloroform/isoamyl alcohol (24:1). Genomic DNA was then precipitated
from the final aqueous phase by the addition of two volumes of 95%
ethanol. The DNA precipitate was spooled out with a glass rod, washed
with 70% ethanol, dried, and resuspended in 10 mM Tris, pH 8, and 1 mM
EDTA. The DNA was allowed to slowly resuspend for several days at
4°C. DNA concentrations were estimated by measuring the absorbance at
260 nm of a 1:100 dilution of two or four replicates of each sample.
Southern Transfer and Hybridization.
Genomic DNA was
digested with 10 to 20 U of the appropriate restriction endonuclease
and electrophoresed on an 0.8% agarose gel. The restriction enzymes
that were tested include AvaI, BamHI, BglI, BglII, DraI, EcoRI,
EcoRV, HaeII, HincII,
HindIII, HinfI, KpnI, MspI,
NciI, NotI, PstI, PvuI,
RsaI, SacI, SctI, StuI,
StyI, TaqI, and XbaI. The gel was
subsequently transferred to a nylon membrane (Gene Screen Plus; New
England Nuclear, Boston, MA) by capillary action as described elsewhere
(Sambrook et al., 1989
). Once the transfer was complete, the membrane
was placed in a UV transluminator (Stratagene, La Jolla, CA) to
covalently link the DNA to the membrane. Membranes were prehybridized
for 30 min at 65°C in Rapid Hyb (Amersham Corp, Arlington Heights,
IL) hybridization solution (0.2 ml/cm2). A
radiolabeled [
-32P]dCTP (New England
Nuclear) full-length probe was generated by a random priming method
(Feinberg and Vogelstein, 1983
) for each of the subunits tested, using
a commercially available kit (Decaprime II; Ambion, Austin, TX), and
subsequently added (2 ng/ml) to the solution. For
2,
3,
4,
5,
6, and
4 probes, rat cDNAs, generously provided by Dr. Jim
Boulter (University of California at Los Angeles), were cut from their
respective vectors and gel purified before use. The
7 and
2
probes were derived from gel-purified mouse cDNA clones. After a 3-h
hybridization at 65°C, membranes were washed at increasing
stringencies until the background was not detectable with a Geiger
counter. For most experiments, the final wash was at 65°C and
consisted of 0.5× SSC (1× SSC = 150 mM NaCl, 15 mM sodium
citrate, pH 7.0) and 0.1% SDS. Membranes were then exposed to X-ray
film (Kodak XAR-5) at
70°C with an intensifying screen for 1 to 7 days. After exposure, films were evaluated by two independent observers
for RFLPs. Each nicotinic receptor subunit cDNA probe produced a unique
hybridization pattern. This indicates that the probes did not
cross-hybridize with the other nicotinic receptor subunits. All
potential RFLPs were confirmed by repeating the Southern analysis.
Data Analysis.
The effective dose that produced seizures in
50% of the animals (ED50 value) was calculated
for each strain using a regression line comparison program (Diem and
Lentner, 1970
). The ED50 and latency to seizure
data were analyzed initially using a 3-way ANOVA that tested for
significant overall effects of strain, or genotype, gender, and dose.
The potential effect of genotype (RFLP status) on seizure sensitivity
was assessed by comparing the mean ED50 values of
the RI strains that have the LS-like RFLP with the mean
ED50 values of the RI strains that have the
SS-like RFLP using a t test. Only 22 of the 26 RI strains
were genotyped because four of the strains were lost between the time
of behavioral testing and time of genotyping. The strains were lost
because of reduced fertility, and unfortunately, we did not retain DNA
samples so that the genotyping could be done. Potential correlations
between the ED50 values and seizure latencies of
the RI strains were assessed separately for females and males for both
of the doses (3.5 and 4.0 mg/kg) that were tested in all of the strains.
| |
Results |
|---|
|
|
|---|
Figure 1 presents dose-response
curves for nicotine-induced seizures obtained from the parental LS and
SS lines and four of the RI strains (genders combined). The RI strains
selected represent the phenotypic extremes. A dose-dependent increase
in the fraction of animals that showed a clonic seizure after i.p.
nicotine injection was observed in all of the strains.
ED50 values for nicotine-induced seizures were
calculated for both genders in each of the strains and are listed in
Table 1. No significant difference in
seizure sensitivity, as measured by ED50 value,
was observed between the LS and SS mice. However, a significant overall
effect of strain (F25,51 = 2.36, P < .05) was observed in the RI strains. In addition, an overall effect of gender (F1,51 = 7.70, P < .01) was observed; the females were more
sensitive to the seizure-inducing effects of nicotine. As depicted in
Fig. 2, the RI strains showed a wide range in seizure sensitivity, as measured by ED50
values, for both females (left) and males (right). A nearly 3-fold
difference in ED50 values was observed between
the most sensitive and the least sensitive strains. The strain
distribution pattern for the ED50 values also
approximates a normal distribution for both sexes. The gene estimate
obtained (gender combined), using the methods described in Data
Analysis, is 5.04. Thus, sensitivity to the seizure-inducing
effects of nicotine is a polygenically regulated trait.
|
|
|
The time between nicotine injection and emergence of a clonic seizure
(seizure latency) was also measured in the LS, SS, and RI animals. The
seizure latencies in the LS and SS mice were 229.4 ± 16.9 (LS)
and 268.5 ± 14.6 (SS) after 3.0 mg/kg. LS
SS results obtained with 3.5 and 4.0 mg/kg are presented in Table 1 along with
results obtained for the RI strains after the 3.5 and 4.0 mg/kg doses
(the only doses that were used in all of the strains). A significant
LS
SS difference in seizure latency (LS more sensitive than SS)
was observed when the data obtained using the 3.0, 3.5, and 4.0 mg/kg
doses (the three doses that were tested in both mouse lines) were
analyzed (F1,162 = 4.54, P < .05).
Figure 3 presents an analysis of the
relationship between seizure latency after a nicotine injection of 3.5 or 4.0 mg/kg and ED50 values for the RI strains.
The 3.5 and 4.0 mg/kg doses were used for this analysis because these
were the only test doses that were used in all of the RI strains.
Seizure latency was significantly affected by strain
(F24,1188 = 9.59, P < .001), gender (F1,1188 = 22.15, P < .001), and dose
(F1,1188 = 87.45, P < .001). The relationship between seizure latency and
ED50 in females is presented in the left panel of
Fig. 3, whereas the right panel depicts the data obtained with males.
Females had a shorter latency to seize than males, and the latency was
shorter after treatment with the higher (4.0 mg/kg) nicotine dose than
it was after injection with 3.5 mg/kg. A significant strain × gender interaction was also detected
(F24,1188 = 1.82, P < .01). Significant correlations between seizure latencies and
ED50 values were obtained in both genders at both
doses (all P values <.001). Thus,
ED50 values and seizure latencies provide similar
measures of seizure sensitivity. The number of genes that
regulate latency to seizures (gender combined) was estimated as 2.64 for the 3.5 mg/kg dose and as 3.57 for the 4.0 mg/kg dose.
|
To determine whether the parental LS and SS lines exhibit RFLPs for
nicotinic receptor genes, DNA isolated from the LS and SS mice was
screened for RFLPs in the
2,
3,
4,
5,
6,
7,
2, and
4 using a panel of 24 restriction endonucleases. Table 2 presents these results. Although RFLPs
were detected between the LS and SS for the
2,
3,
4,
5, and
6 nicotinic receptor subunit genes, only the
4 and
6 RFLPs
were found in the RI strains. The genotype of the
4 and
6 subunit
genes for each of the RI strains was designated as either LS-like or
SS-like depending on its RFLP status. Figure
4 provides an illustration of the RFLPs detected in the LS and SS mice for the
4 and
6 genes.
|
|
The relationships between the
4 RFLP and ED50
values for nicotine-induced seizures are presented in Fig.
5. Figure 5 (top) depicts the strain
distribution pattern for the
4 RFLP contrasted against the
ED50 value for nicotine-induced seizures in
females, and the bottom panel presents the results obtained with males. In both genders, most of the strains with a low
ED50 value for nicotine-induced seizures have the
LS
4 RFLP, whereas most of the RI strains with a high
ED50 value have the SS
4 RFLP. Figure 5
(insets) presents a comparison of the mean seizure
ED50 across
4 genotype. The mean
ED50 value in males of those strains with the LS
4 RFLP (3.84 ± 0.27 mg/kg) is significantly lower than the
mean ED50 value of those strains with the SS
4
(4.64 ± 0.27 mg/kg) (t22 = 2.10, P < .05). In females, those strains with the LS
4 genotype have a mean ED50 value of
3.17 ± 0.21 mg/kg, whereas the mean ED50
obtained in those strains with the SS
4 genotype is 3.73 ± 0.26 mg/kg. This apparent difference is not significant (t22 = 1.65, P = .12).
|
The effect of
4 RFLP on seizure latency is presented in Fig.
6. A significant effect of genotype (
4
RFLP) was observed at both the 3.5 mg/kg
(F1,609 = 9.79, P < .01) and 4.0 mg/kg (F1,598 = 5.84, P < .02) doses of nicotine. The LS
4 RFLP led to a
shorter seizure latency in both sexes at both nicotine doses. In
addition, gender also affected seizure latency at both doses (3.5 mg/kg: F1,609 = 14.69, P < .001; 4.0 mg/kg:
F1,598 = 7.77, P < .01); the latency to seize was less in females.
|
Figure 7 provides the strain distribution
pattern for the
6 RFLP contrasted against ED50
value. The top panel of this figure presents the data obtained with the
females, and the bottom panel presents the data obtained with the
males. In females, the LS
6 RFLP was found primarily in those RI
strains that were less sensitive (higher ED50
values) to nicotine-induced seizures. This is demonstrated in Fig. 7
(top inset), where the mean ED50 values for the
LS and SS
6 genotypes are presented. Females with the LS
6
genotype had a mean ED50 value of 3.84 ± 0.22 mg/kg, whereas females of those strains with the SS
6 genotype
had a mean ED50 value of 2.89 ± 0.20 mg/kg.
This difference is significant (t21 = 3.22, P < .01). The effect of the
6 genotype was
not significant in males. The mean ED50 value in
males with the LS
6 genotype is 4.39 ± 0.29 mg/kg, whereas the
mean of males with the SS genotype is 4.03 ± 0.29 mg/kg
(t21 = 0.90, P = 0.38).
|
The influence of
6 RFLP on seizure latency is shown in Fig.
8. A significant overall effect of
genotype was detected at the 3.5 mg/kg dose
(F1,586 = 11.36, P = 0.001). A main effect of gender was also observed
(F1,586 = 15.51, P < .001). In addition, a significant genotype × gender interaction
was detected (F1,586 = 5.88, P < .05). This interaction arises because no effect of
6 genotype was seen in males after injection with the 3.5 mg/kg
nicotine dose. Significant effects of both genotype
(F1,582 = 23.16, P < .001) and gender (F1,582 = 9.42, P < .01) were seen in those animals that were treated
with the 4.0 mg/kg nicotine dose. Those RI strains that have the LS
6 RFLP tended to have a longer latency to seizures after nicotine
injection than did those RI strains that have the SS
6 RFLP.
|
| |
Discussion |
|---|
|
|
|---|
Several earlier studies demonstrated that the LS mice are slightly
more sensitive than the SS mice to nicotine-induced seizures, as
measured by ED50 values (de Fiebre et al., 1987
;
de Fiebre and Collins, 1992
). A significant LS
SS difference in
ED50 values was not seen in the study reported
here, but when seizure latency was used as the measure, the LS mice
were more sensitive than the SS to the seizure-inducing effects of
nicotine. The seizure sensitivities of the parental LS and SS lines
were in the midrange of seizure sensitivity compared with the RI
strains. This could occur only if the LS mice do not have all of the
genes that result in a high sensitivity to nicotine-induced seizures
and the SS mice do not have all of the genes that result in reduced
sensitivity. The findings that the LS
4 RFLP is associated with
increased sensitivity to seizures and the LS
6 RFLP is associated
with reduced sensitivity to seizures are consistent with this conclusion.
Estimates of the number of genes that regulate seizure sensitivity
yielded values that ranged from three to five. It must be recognized
that these estimates are dependent on the validity of several
assumptions (Falconer, 1981
). One of these assumptions is that the
genes act in an additive fashion without epistasis (gene-gene
interaction). However, epistasis was detected by de Fiebre and Collins
(1992)
in a study that evaluated the seizure sensitivity of F1, F2, and
backcross generations derived from the LS and SS mice. Consequently,
the gene estimates reported here should not be taken literally and are
likely to be an underestimate of the number of genes that regulate
nicotine-induced seizures.
The mRNA for the
4 nicotinic receptor subunit is widely distributed
in mouse brain (Marks et al., 1992
; Marubio et al., 1999
) and, in
combination with the
2 subunit, makes up the vast majority of
high-affinity agonist (e.g., [3H]nicotine)
binding sites in brain (Whiting and Lindstrom, 1988
; Picciotto et al.,
1995
; Marubio et al., 1999
). Many, if not nearly all, of the
4
2-type nicotinic receptors are found on presynaptic nerve
terminals (Wonnacott, 1997
). They apparently modulate the release of
the inhibitory neurotransmitter
-aminobutyric acid (GABA; Léna
and Changeux, 1997
; Lu et al., 1998
; Alkondon et al., 1999
). As noted
by Alkondon et al. (1997)
, desensitization of this receptor could
result in a decrease in GABA release and cause convulsions by producing
disinhibition. This postulate is supported by the observation that
injection with the
4
2-selective nicotinic antagonist
dihydro-
-erythroidine elicits seizures in the rat (Felix and Levin,
1997
) and the mouse (Marubio et al., 1999
). Moreover, a genetically
determined form of epilepsy found in humans seems to be due to a
mutation of the
4 nicotinic receptor (Steinlein et al., 1995
). The
mutation results in a receptor that desensitizes faster than does the
wild-type receptor (Weiland et al., 1996
). Thus, it may be that the
association between the
4 RFLP and nicotine-induced seizure
sensitivity is due to a difference in the
4 gene that leads to
differences in GABAergic activity.
Females were slightly more sensitive to the seizure-inducing effects of
nicotine as determined by both ED50 value and
seizure latency. This might be due to differences in nicotine
metabolism or distribution because both LS and SS females have higher
brain levels of nicotine, after i.p. injection, than do the males (de Fiebre et al., 1987
). However, two studies (Ke and Lukas, 1996
; Bullock
et al., 1997
) have demonstrated that progesterone and some of its
metabolites are allosteric inhibitors of several neuronal nicotinic
receptors. If desensitization of the
4
2-type nicotinic receptor
promotes nicotine-induced seizures, it may be that inhibition of this
receptor by progesterone or one of its metabolites results in a
functional equivalent of desensitization, thereby promoting seizures.
The
6 subunit is found principally in nuclei where dopaminergic
neurons are found (Le Novère et al., 1996
). Because nicotine stimulates the release of dopamine (Rowell et al., 1987
; Rapier et al.,
1988
; Grady et al., 1997
), it has been suggested, but not yet been
demonstrated, that the
6 subunit is a member of the nicotinic
receptor or receptors that modulate dopamine release (Le Novère
et al., 1996
). Dopamine plays a role in regulating the potency and
efficacy of a broad array of seizure-inducing drugs (e.g., see Hoffman
et al., 1997
; Lindsey et al., 1998
). Thus, it may be that a
polymorphism associated with the
6 gene regulates nicotine-induced
seizures by influencing the activity of dopaminergic neurons.
It is also possible that one or more genes that are tightly linked to
these nicotinic receptor subunit genes is involved in regulating the
seizure response. Although it seems logical that variability in seizure
sensitivity to nicotine-induced seizures might be due to variability in
nicotinic receptors, RFLP analysis does not prove that a mutation
associated with the marker gene (in this case,
4 or
6 nicotinic
receptor subunit genes) causes a difference in the amount or activity
of protein derived from the gene. Further studies must be performed to
sort out whether polymorphisms in the
4 or
6 genes or genes
closely linked to them regulate the genetic influences in seizure
sensitivity seen in the study reported here.
The LS and SS mice were selectively bred for differences in duration of
loss of the righting response (sleep time) after i.p. injection of high
doses of ethanol. The major cause of the LS
SS difference in
response to the sleep-time inducing (anesthetic) effects of ethanol
arises because of differential central nervous system sensitivity to
ethanol, as demonstrated by the fact that the LS mice lose and regain
the righting response at lower blood and brain concentrations of
ethanol than do the SS mice (e.g., see Erwin et al., 1988
; Finn et al.,
1991
). At least in theory, selective breeding should have led to a
situation where the LS mice are isogenic (usually homozygous) for all
of the genes that promote an increase in ethanol-induced sleep time and
the SS mice should be isogenic for the genes that result in a decreased
sensitivity to ethanol. Thus, the finding that the LS and SS mouse
lines are homozygous for RFLPs associated with the
4 and
6
nicotinic receptor genes implicates a role for these nicotinic receptor
subunits in regulating the anesthetic actions of ethanol. This
suggestion should be accepted cautiously, however, because homozygosity
might have been obtained as a consequence of unwanted inbreeding. If inbreeding resulted in fixation of either the
4 of
6 genes, these
nicotinic receptor subunits would not play a role in regulating the
many effects of alcohol.
Evidence obtained by others suggests that the
4
2-type nicotinic
receptor may be a critical site of action of alcohol. Ethanol, at
concentrations less than 100 mM, enhances the nicotinic activation of
4
2 receptors expressed in oocytes (Cardoso et al., 1999
). Similarly, ethanol enhances electrical currents in rat cortical cells
in culture (Aistrup et al., 1998
; Marszalec et al., 1999
). The currents
affected by ethanol in rat cortical cells most probably arise as a
consequence of activation of
4
2-containing receptors. These
provocative findings suggest that further studies of the role of the
4 nicotinic receptor subunit in regulating behavioral responses to
both nicotine and ethanol are warranted.
Virtually nothing is known about the function of the
6 nicotinic
receptor subunit, but it could be that the same property of the
6
receptor that makes an animal more sensitive to the seizure-inducing
effects of nicotine makes the animal less sensitive to the behavioral
effects of alcohol. The finding that the
6 nicotinic receptor
subunit may be different in the LS and SS mice indicates that the
potential role of this subunit in regulating the actions of alcohol
should be evaluated.
| |
Acknowledgments |
|---|
We are indebted to Elena Romm, Doug Farnham, and Cameron Backer for assistance with the seizure testing and to Dawn Caillouet for assistance in preparation of the manuscript.
| |
Footnotes |
|---|
Accepted for publication December 9, 1999.
Received for publication July 23, 1999.
1 This work was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (AA11156) and the National Institute on Drug Abuse (DA10156). A.C.C. is supported in part by a Research Scientist Award from the National Institute on Drug Abuse (DA00197).
Send reprint requests to: Dr. Allan C. Collins, Institute for Behavioral Genetics, CB 447, University of Colorado, Boulder, CO 80309-0447. E-mail: al.collins{at}colorado.edu
| |
Abbreviations |
|---|
LS, Long-Sleep;
SS, Short-Sleep;
RI, recombinant inbred;
RFLP, restriction fragment length polymorphism;
GABA,
-aminobutyric acid.
| |
References |
|---|
|
|
|---|
6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain.
Eur J Neurosci
8:
2428-2439[Medline].
-bungarotoxin-insensitive nicotinic acetylcholine receptors in rat cortical neurons.
Alcohol Clin Exp Res
23:
439-445[Medline].
4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.
Nat Genet
11:
201-203[Medline].This article has been cited by other articles:
![]() |
R. C. Drisdel, D. Sharp, T. Henderson, T. G. Hales, and W. N. Green High Affinity Binding of Epibatidine to Serotonin Type 3 Receptors J. Biol. Chem., April 11, 2008; 283(15): 9659 - 9665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kedmi, A. L. Beaudet, and A. Orr-Urtreger Mice lacking neuronal nicotinic acetylcholine receptor {beta}4-subunit and mice lacking both {alpha}5- and {beta}4-subunits are highly resistant to nicotine-induced seizures Physiol Genomics, April 13, 2004; 17(2): 221 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Butt, N. M. King, J. A. Stitzel, and A. C. Collins Interaction of the Nicotinic Cholinergic System with Ethanol Withdrawal J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 591 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dobelis, S. Hutton, Y. Lu, and A. C. Collins GABAergic Systems Modulate Nicotinic Receptor-Mediated Seizures in Mice J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1159 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salas, A. Orr-Urtreger, R. S. Broide, A. Beaudet, R. Paylor, and M. De Biasi The Nicotinic Acetylcholine Receptor Subunit alpha 5 Mediates Short-Term Effects of Nicotine in Vivo Mol. Pharmacol., May 1, 2003; 63(5): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dobelis, M. J. Marks, P. Whiteaker, S. A. Balogh, A. C. Collins, and J. A. Stitzel A Polymorphism in the Mouse Neuronal alpha 4 Nicotinic Receptor Subunit Results in An Alteration in Receptor Function Mol. Pharmacol., August 1, 2002; 62(2): 334 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Broide, R. Salas, D. Ji, R. Paylor, J. W. Patrick, J. A. Dani, and M. De Biasi Increased Sensitivity to Nicotine-Induced Seizures in Mice Expressing the L250T alpha 7 Nicotinic Acetylcholine Receptor Mutation Mol. Pharmacol., March 1, 2002; 61(3): 695 - 705. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||